Andrzej Deptała Selected Research

caspase-activated DNase inhibitor

10/2018

Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrzej Deptała Research Topics

Disease

11	Neoplasms (Cancer) 04/2021 - 01/2004
5	Pain (Aches) 02/2018 - 07/2016
3	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2016
2	Carcinoma (Carcinomatosis) 10/2017 - 07/2016
1	Inflammation (Inflammations) 05/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Cytokine Release Syndrome 01/2021
1	Cachexia 01/2021
1	Starvation 01/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 09/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2020
1	Kidney Neoplasms (Kidney Cancer) 09/2020
1	Macular Degeneration (Age-Related Maculopathy) 09/2020
1	Multiple Sclerosis 09/2020
1	Nervous System Diseases (Neurological Disorders) 09/2020
1	Parkinson Disease (Parkinson's Disease) 09/2020
1	Lymphoma (Lymphomas) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2018
1	Infections 09/2018
1	Hepatitis 09/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Overweight 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Liver Neoplasms (Liver Cancer) 01/2012
1	Hypoxia (Hypoxemia) 01/2012
1	Plasmacytoma 01/2004

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2018
1	Complement System Proteins (Complement)IBA 05/2022
1	Progesterone FDA LinkGeneric 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Progestins (Progestagens)IBA 01/2021
1	Interleukin-1 (Interleukin 1)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Protein AggregatesIBA 09/2020
1	Crystallins (Crystallin)IBA 09/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	caspase-activated DNase inhibitorIBA 10/2018
1	Immunoglobulin G (IgG)IBA 09/2018
1	Hepatitis A AntibodiesIBA 09/2018
1	Immunoglobulin M (IgM)IBA 09/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	LeptinIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Coffee FDA Link 10/2016
1	TeaIBA 10/2016
1	Hormones (Hormone)IBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Sorafenib (BAY 43-9006)FDA Link 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012

Therapy/Procedure

7	Therapeutics 01/2022 - 07/2016
5	Pain Management 10/2017 - 01/2016
4	Drug Therapy (Chemotherapy) 05/2022 - 01/2012
1	Transplantation 05/2022
1	Mechanical Ventilators (Ventilator) 04/2021
1	Remission Induction 01/2020
1	Secondary Prevention 04/2018
1	Dietary Approaches To Stop Hypertension 01/2018
1	Aftercare (After-Treatment) 01/2013
1	Radiotherapy 01/2004